Exchange: NASDAQ·Updated 04:10 AM EDT
IRON logo

IRON Disc Medicine Inc

$79.00
$0.37
(0.47%)
Pre-Market
Prev Close $79.37
EarningsNov 5
Mkt Cap$3.07B
Vol2.00

About IRON

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.
40

Bearish Sentiment

How do you feel about IRON?

Advertisement|Remove ads.